AHCO - Company ID 0001725255
The table below shows AdaptHealth Corp.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $93.72M | $95.53M | $49.03M | $140.25M | $66.45M | $18.38M |
| Capital expenditure | $121.21M | $95.58M | $87.89M | $89.12M | $77.17M | $35.60M |
| Investing cash flow | -$204.46M | -$95.58M | -$87.89M | -$89.57M | -$80.10M | -$1.21B |
| Dividends paid | - | - | - | - |
AdaptHealth Corp. reported operating cash flow of $601.77M for fiscal year 2025. That is up 11.1% from $541.84M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from $68.43M (FY 2018) to $601.77M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | $0.00 | $9.22M | $0.00 | - |
| Financing cash flow | $52.56M | -$56.04M | $41.29M | $4.45M | -$16.55M | $1.23B |